Where do artificial intelligence and robotics fit into discoveries? In this session of the Newton Series, Steve Finkbeiner, MD, PhD, explains how these tools contribute to his lab’s work in understanding the fundamentals of brain cells, which he hopes will lead to discoveries in memory diseases like Alzheimer’s or Parkinson’s.
The Newton Webinar Series is inspired by the story of Isaac Newton’s extraordinary intellectual output while in quarantine during the Great London Plague of 1665, and offers an alternative to all the news related to COVID-19. Each week, we feature a conversation with Gladstone’s scientists and explore their moonshot ideas, how they approach their work, and what they think medicine may look like 10, 20, and 50 years from now.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Meet Gladstone: Leandro Lima
Article
October 13, 2020
Meet Gladstone: Leandro Lima
Learn how a Gladstone bioinformatician is spending his days during shelter-in-place
Profile Bioinformatics Core Finkbeiner LabData-Driven Discovery
Article
April 22, 2020
Data-Driven Discovery
Many Gladstone researchers rely on computational approaches, machine learning, and innovative software to make biomedical discoveries.
Gladstone Experts Bioinformatics Core HIV/AIDS Zika Virus Center for HIV Cure Research Center for Systems and Therapeutics Data Science and Biotechnology Neurological Disease Virology Finkbeiner LabAging: Progress with Rejuvenation and Regeneration
Video
February 20, 2020
Aging: Progress with Rejuvenation and Regeneration
Aging is the single greatest risk factor for developing Alzheimer’s disease, Parkinson’s disease, and other brain diseases.
Gladstone Experts Cardiovascular Disease Neurological Disease Finkbeiner Lab McDevitt Lab Srivastava Lab Aging